Abstract
Bleomycins are a group of glycopeptide antibiotics synthesized by Streptomyces verticillus that are widely used for the treatment of various neoplastic diseases. These antibiotics have the ability to chelate a metal center, mainly Fe(II), and cause site-specific DNA cleavage. Bleomycins are differentiated by their C-terminal regions. Although this antibiotic family is a successful course of treatment for some types of cancers, it is known to cause pulmonary fibrosis. Previous studies have identified that bleomycin-related pulmonary toxicity is linked to the C-terminal region of these drugs. This region has been shown to closely interact with DNA. We examined the binding of Zn(II)peplomycin and Zn(II)bleomycin-A2 to a DNA hairpin of sequence 5′-CCAGTATTTTTACTGG-3′, containing the binding site 5′-GT-3′, and compared the results with those obtained from our studies of the same MBLMs bound to a DNA hairpin containing the binding site 5′-GC-3′. We provide evidence that the DNA base sequence has a strong impact in the final structure of the drug–target complex.
Similar content being viewed by others
Abbreviations
- A:
-
Adenine
- Ala:
-
β-Aminoalanine
- Bit:
-
Bithiazole
- BLMs:
-
Bleomycins
- C:
-
Cytosine
- 1D:
-
One dimensional
- 2D:
-
Two dimensional
- Δδs:
-
Differences in chemical shifts
- Δω :
-
Difference in peak width
- FID:
-
Free induction decay
- G:
-
Guanine
- Gul:
-
α-l-Gulose
- Hist:
-
β-Hydoxyhistidine
- Mann:
-
α-d-Mannose
- MBLMs:
-
Metallo-bleomycins
- NMR:
-
Nuclear magnetic resonance
- NOE:
-
Nuclear Overhauser effect cross signals
- NOESY:
-
Nuclear Overhauser effect spectroscopy
- OL:
-
Oligonucleotide
- OL1 :
-
5′-AGCCTTTTGGCCT-3′
- OL2 :
-
5′-CCAGTATTTTTACTGG-3′
- PEP:
-
Peplomycin
- ppm:
-
Parts per million
- Pyr:
-
Pyrimidinyl propionamide
- SDS:
-
Sodium dodecyl sulfate
- T:
-
Thymine
- Tails:
-
C-terminus substituents
- Thr:
-
Threonine
- TOCSY:
-
Totally correlated spectroscopy
- Val:
-
Methylvalerate
References
Umezawa H, Maeda K, Takeuchi T, Okami Y (1966) J Antibiot 19:200–209
Bennett JM, Reich SD (1979) Ann Intern Med 90:945–948
Gobbi PG, Federico M (2012) CRC Cr Rev Oncol Hem 82:18–24
Einhorn LH, Donohue J (1977) Ann Intern Med 87:293–298
Carlson RW, Sikic BI, Turbow MM, Ballon SC (1983) J Clin Oncol 1:645–651
Batist G, Andrews JL (1981) JAMA 246:1449–1453
Raisfeld IH, Chovan JP, Frost S (1982) Life Sci 30:1391–1398
Raisfeld IH (1979) Clin Res 27:A445
Raisfeld IH (1980) Clin Res 28:A530
Raisfeld IH (1980) Toxicol Appl Pharm 56:326–336
Raisfeld IH, Kundahl ER, Sawey MJ, Chovan JP, Depasquale J (1982) Clin Res 30:A437
Raisfeld IH (1981) Clin Pharm Ther 29:274
Tanaka W, Takita T (1979) Heterocycles 13:469–476
Oka S (1980) Recent Results Cancer Res 74:163–171
Takahashi K, Ekimoto H, Aoyagi S, Koyu A, Kuramochi H, Yoshioka O, Matsuda A, Fujii A, Umezawa H (1979) J Antibiot 32:36–42
Umezawa H (1976) J Nat Prod 39:467
Manderville RA, Ellena JF, Hecht SM (1995) J Am Chem Soc 117:7891–7903
Sucheck SJ, Ellena JF, Hecht SM (1998) J Am Chem Soc 120:7450–7460
Kuwahara J, Sugiura Y (1988) Proc Natl Acad Sci USA 85:2459–2463
Wu W, Vanderwall DE, Turner CJ, Kozarich JW, Stubbe J (1996) J Am Chem Soc 118:1281–1294
Wu W, Vanderwall DE, Stubbe JA, Kozarich JW, Turner CJ (1994) J Am Chem Soc 116:10843–10844
Wu W, Vanderwall DE, Turner CJ, Hoehn S, Chen JY, Kozarich JW, Stubbe J (2002) Nucleic Acids Res 30:4881–4891
Goodwin KD, Lewis MA, Long EC, Georgiadis MM (2008) Proc Natl Acad Sci USA 105:5052–5056
D’Andrea AD, Haseltine WA (1978) Proc Natl Acad Sci USA 75:3608–3612
Takeshita M, Grollman AP, Ohtsubo E, Ohtsubo H (1978) Proc Natl Acad Sci USA 75:5983–5987
Sausville EA, Peisach J, Horwitz SB (1976) Biochem Biophys Res Commun 73:814–822
Sausville EA, Stein RW, Peisach J, Horwitz SB (1978) Biochemistry 17:2746–2754
Segerman ZJ, Roy B, Hecht SM (2013) Biochemistry 52:5315–5327
Hoehn ST, Junker HD, Bunt RC, Turner CJ, Stubbe J (2001) Biochemistry 40:5894–5905
Lui SM, Vanderwall DE, Wu W, Tang XJ, Turner CJ, Kozarich JW, Stubbe J (1997) J Am Chem Soc 119:9603–9613
Vanderwall DE, Lui SM, Wu W, Turner CJ, Kozarich JW, Stubbe J (1997) Chem Bio 4:373–387
Wu W, Vanderwall DE, Lui SM, Tang XJ, Turner CJ, Kozarich JW, Stubbe J (1996) J Am Chem Soc 118:1268–1280
Wu W, Vanderwall DE, Teramoto S, Lui SM, Hoehn ST, Tang XJ, Turner CJ, Boger DL, Kozarich JW, Stubbe J (1998) J Am Chem Soc 120:2239–2250
Zhao CQ, Xia CW, Mao QK, Forsterling H, DeRose E, Antholine WE, Subczynski WK, Petering DH (2002) J Inorg Biochem 91:259–268
Ehrenfeld GM, Shipley JB, Heimbrook DC, Sugiyama H, Long EC, Vanboom JH, Vandermarel GA, Oppenheimer NJ, Hecht SM (1987) Biochemistry 26:931–942
Lehmann TE, Murray SA, Ingersoll AD, Reilly TM, Follett SE, Macartney KE, Harpster MH (2017) J Bio. Inorg Chem 22(121):136
Umezawa H (1997) In: Hecht SM (ed) Bleomycin: chemical, biochemical and biological aspects. Springer, New York, pp 24–36
Lehmann TE, Serrano ML, Que L Jr (2000) Biochemistry 39:3886–3898
Lehmann TE (2002) J Biol Inorg Chem 7:305–312
Lehmann TE, Li Y (2012) J Antibiot 65:25–33
Lehmann TE, Li Y (2012) J Biol Inorg Chem 17:761–771
Li Y, Lehmann TE (2012) J Inorg Biochem 111:50–58
Raisfeld IH, Chu P, Hart NK, Lane A (1982) Toxicol Appl Pharm 63:351–362
Ito K, Handa J, Irie Y, Ezura H, Kumagai M, Irie Y, Suzuki A, Hagiwara T, Yamane H, Miyamoto K, Yamashita T, Tsubosaki M, Matsuda AN, Konoha N (1979) J Antibiot 32:387–450
Tataurov AV, You Y, Owczarzy R (2008) Biophys Chem 133:66–70
Ren JS, Chaires JB (1999) Biochemistry 38:16067–16075
Ren JS, Chaires JB (2001) Drug Nucleic Acid Interact 340:99–108
Wheelhouse RT, Chaires JB (2010) In: Fox KR (ed) Drug-DNA interaction protocols, pp 55–70
Chaires JB (2005) In: Waring MJ, Chaires JB (eds) DNA binders and related subjects. Springer, Berlin, pp 33–53
Chien M, Grollman AP, Horwitz SB (1977) Biochem 16:3641–3647
Abraham AT, Zhou X, Hecht SM (2001) J Am Chem Soc 12:5167–5175
Feigon J, Denny WA, Leupin W, Kearns DR (1984) J Med Chem 27:450–465
Acknowledgements
This work was supported in whole by the National Institute of Health [Grant R15GM106258]. Our gratitude also goes to Nippon Kayaku Co., Ltd. (Tokyo, Japan) for the generous gift of peplomycin. We also acknowledge Dr. Alexander Goroncy for help collecting the NMR data presented in this work.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Follett, S.E., Ingersoll, A.D., Murray, S.A. et al. Interaction of Zn(II)bleomycin-A2 and Zn(II)peplomycin with a DNA hairpin containing the 5′-GT-3′ binding site in comparison with the 5′-GC-3′ binding site studied by NMR spectroscopy. J Biol Inorg Chem 22, 1039–1054 (2017). https://doi.org/10.1007/s00775-017-1482-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-017-1482-z